SE457693B - Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas - Google Patents

Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Info

Publication number
SE457693B
SE457693B SE8602931A SE8602931A SE457693B SE 457693 B SE457693 B SE 457693B SE 8602931 A SE8602931 A SE 8602931A SE 8602931 A SE8602931 A SE 8602931A SE 457693 B SE457693 B SE 457693B
Authority
SE
Sweden
Prior art keywords
phase
monoglyceride
composition according
triglyceride
active material
Prior art date
Application number
SE8602931A
Other languages
English (en)
Swedish (sv)
Other versions
SE8602931D0 (sv
SE8602931L (sv
Inventor
S Engstroem
K Larsson
B Lindman
Original Assignee
Drilletten Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drilletten Ab filed Critical Drilletten Ab
Priority to SE8602931A priority Critical patent/SE457693B/sv
Publication of SE8602931D0 publication Critical patent/SE8602931D0/xx
Priority to CA000538239A priority patent/CA1296631C/en
Priority to PCT/SE1987/000279 priority patent/WO1988000059A1/en
Priority to AT87904411T priority patent/ATE74277T1/de
Priority to DE87904411T priority patent/DE3778024D1/de
Priority to JP62504060A priority patent/JPH0759523B2/ja
Priority to EP19870904411 priority patent/EP0314689B1/de
Publication of SE8602931L publication Critical patent/SE8602931L/
Priority to NO880560A priority patent/NO175454C/no
Priority to DK105888A priority patent/DK105888A/da
Priority to FI886055A priority patent/FI97687C/fi
Publication of SE457693B publication Critical patent/SE457693B/sv
Priority to US08/107,908 priority patent/US5371109A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE8602931A 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas SE457693B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8602931A SE457693B (sv) 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
CA000538239A CA1296631C (en) 1986-07-01 1987-05-28 Controlled-release composition
EP19870904411 EP0314689B1 (de) 1986-07-01 1987-06-12 Zubereitung eines in einer l2-phase gelösten oder dispergierten biologischen aktiven materials mit geregelter verabreichung
DE87904411T DE3778024D1 (de) 1986-07-01 1987-06-12
AT87904411T ATE74277T1 (de) 1986-07-01 1987-06-12 Zubereitung eines in einer l2-phase geloesten oder dispergierten biologischen aktiven materials mit geregelter verabreichung.
PCT/SE1987/000279 WO1988000059A1 (en) 1986-07-01 1987-06-12 A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase
JP62504060A JPH0759523B2 (ja) 1986-07-01 1987-06-12 調節放出組成物
NO880560A NO175454C (no) 1986-07-01 1988-02-09 Fremgangsmåte for fremstilling av et preparat som har form av en L2-fase
DK105888A DK105888A (da) 1986-07-01 1988-02-29 Farmaceutisk middel med kontrolleret frigivelse af det biologisk aktive materiale samt fremgangsmaade til fremstilling af et saadant middel
FI886055A FI97687C (fi) 1986-07-01 1988-12-30 Säännöstellysti vapauttava koostumus L2-faasiin liuotettua tai dispergoitua biologisesti aktiivista ainetta varten
US08/107,908 US5371109A (en) 1986-07-01 1993-08-18 Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8602931A SE457693B (sv) 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Publications (3)

Publication Number Publication Date
SE8602931D0 SE8602931D0 (sv) 1986-07-01
SE8602931L SE8602931L (sv) 1988-01-02
SE457693B true SE457693B (sv) 1989-01-23

Family

ID=20364989

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602931A SE457693B (sv) 1986-07-01 1986-07-01 Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Country Status (8)

Country Link
EP (1) EP0314689B1 (de)
JP (1) JPH0759523B2 (de)
CA (1) CA1296631C (de)
DE (1) DE3778024D1 (de)
DK (1) DK105888A (de)
FI (1) FI97687C (de)
SE (1) SE457693B (de)
WO (1) WO1988000059A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5196201A (en) * 1989-10-20 1993-03-23 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
DE69025378T2 (de) * 1989-10-20 1996-06-20 Bioapatite Ab Implantatmaterialzusammensetzung, ihre Herstellung sowie ihre Verwendungen und daraus erhältliches Implantat
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
WO1992018147A1 (en) * 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
ES2098739T3 (es) 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
EP0589843B1 (de) 1992-09-25 2001-11-28 Novartis AG Cyclosporin enthaltende pharmazeutische Zusammensetzungen
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
SE518619C2 (sv) * 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
RU2158601C2 (ru) 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
DE29824679U1 (de) 1997-01-30 2002-03-28 Novartis Ag, Basel Pharmazeutische Zusammensetzungen
BR9806238A (pt) * 1997-09-09 2005-07-12 Select Release L C Partìculas revestidas: processos de obtenção e uso
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
CN114145290A (zh) * 2021-06-02 2022-03-08 贵州省烟草科学研究院 高效长效昆虫性诱芯及其制作方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1052697A (en) * 1974-03-29 1979-04-17 Upjohn Company (The) Composition for treating mastitis in animals
JPS6042766B2 (ja) * 1978-12-09 1985-09-25 日本化薬株式会社 基剤
DE3224619A1 (de) * 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung

Also Published As

Publication number Publication date
SE8602931D0 (sv) 1986-07-01
FI97687C (fi) 1997-02-10
DE3778024D1 (de) 1992-05-07
FI886055A (fi) 1988-12-30
FI97687B (fi) 1996-10-31
DK105888D0 (da) 1988-02-29
EP0314689A1 (de) 1989-05-10
JPH01503140A (ja) 1989-10-26
EP0314689B1 (de) 1992-04-01
DK105888A (da) 1988-02-29
JPH0759523B2 (ja) 1995-06-28
SE8602931L (sv) 1988-01-02
CA1296631C (en) 1992-03-03
WO1988000059A1 (en) 1988-01-14

Similar Documents

Publication Publication Date Title
SE457693B (sv) Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
US5371109A (en) Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase
DK175157B1 (da) Mikrokapsler, præparat omfattende sådanne mikrokapsler, en krystaldispersion og fremgangsmåde til fremstilling af mikrokapslerne, henholdsvis præparaterne og krystaldispersionen samt anvendelse af mikropaksler
DE69619700T2 (de) Cyclosporin enthaltende, biologisch aktive zubereitung
CA1336876C (en) Emulsions
DE69110052T2 (de) Zweiphasige freigabezusammensetzungen für lipophile wirkstoffe.
CA2258909A1 (en) Oil containing lipid vesicles with marine applications
SE518578C2 (sv) Lipidbaserad komposition
CN1323579A (zh) 含水溶性美容活性组分水性核的微胶囊及含其的组合物
EP0449983A4 (en) Encapsulation of parasiticides
CN113558223B (zh) 一种双重乳液的制备方法及其在虾青素载运中的应用
CA2862400C (en) Long-acting nanoparticulate arthropod repellent formulations and methods of use thereof
EP0299205B1 (de) Mikrokapseln mit gelenkter Freigabe und Verfahren zu deren Herstellung
CN1775039A (zh) 印楝油微胶囊及其制备方法
Obitte et al. Preliminary studies on two vegetable oil-based self-emulsifying drug delivery system (SEDDS) for the delivery of metronidazole, a poorly water soluble drug
AU2648095A (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
NO175454B (no) Fremgangsmåte for fremstilling av et preparat som har form av en L2-fase
CN102600043A (zh) S/o型混悬液的制造方法
SU1296077A1 (ru) Способ приготовлени корма дл рыб
EP0312578A1 (de) Öl-in-wasser-präparat zur verwendung als pestizide zusammensetzung und verfahren zur bekämpfung von schädlingen damit

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8602931-1

Effective date: 19940210

Format of ref document f/p: F